A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Immunology

Genetics

Virology

In Vitro

Show all topics

DOI

10.1101/2022.09.23.509206

License

cc-no